Oncology Clinical Trials During the COVID-19 Pandemic
Flowchart of included drugs. EMA, European Medicines Agency; FDA, Food... | Download Scientific Diagram
Welcome to CTIS
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States - Cytotherapy
CTIS for sponsors - EMA
Assessment of the Regulatory Dialogue Between Pharmaceutical Companies and the European Medicines Agency on the Choice of Noninferiority Margins - Clinical Therapeutics
Session 2 - Update on implementation of CTR - A.M. Janson Lang
Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non‐orphan, Non‐oncology Drugs in the European Union and United States from 2012−2016 - Morant - 2019 - Clinical and Translational Science - Wiley Online Library
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency | Trials | Full Text
EU Clinical Trials Regulation (EU-CTR) enters application on 31 January 2022
EMA Clinical Trial Information System Summary Status - Acron
EU CTR Frequently Asked Questions
Clinical data publication | European Medicines Agency
The obligatory sharing of clinical trial data in the European Union - datenschutz notizen | News-Blog der datenschutz nord Gruppe
clinical-trials-portal - IDMP1
EMA calls for 'stakeholder' input on design of new clinical trials database
Call for all sponsors to publish clinical trial results in EU database | European Medicines Agency
Lay Summaries of Clinical Study Results: An Overview | SpringerLink
EU's Clinical Trials Regulation and portal goes live 31 January
Clinical Trial Regulation
EU clinical trial portal and database declared functional | RAPS
Clinical Trials in the European Union - EMA
SUSAR reporting | Icelandic Medicines Agency
Material and information about the upcoming CTIS from EMA – Ascro
